<?xml version="1.0" encoding="UTF-8"?>
<p id="par0010">Biotechnology platforms for the rapid high-throughput identification and prioritization of effective therapeutic candidates for multiple indications have the potential to significantly strengthen our response to pathogenic outbreaks and save countless lives 
 <xref rid="bib0005" ref-type="bibr">1</xref>, 
 <xref rid="bib0010" ref-type="bibr">2</xref>, 
 <xref rid="bib0015" ref-type="bibr">3</xref>, 
 <xref rid="bib0020" ref-type="bibr">4</xref>. In response to the current COVID-19 outbreak, numerous technologies, including those based on high throughput protein-protein complex pulldowns and network biology, have been applied to quickly screen and identify drug repurposing candidates that may be rapidly deployed to treat infected individuals without the need for full regulatory approval 
 <xref rid="bib0005" ref-type="bibr">1</xref>, 
 <xref rid="bib0010" ref-type="bibr">2</xref>, 
 <xref rid="bib0025" ref-type="bibr">5</xref>, 
 <xref rid="bib0030" ref-type="bibr">6</xref>.
</p>
